A Phase I/II Study of AGA111 for Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
Clinical trial NCT05574543 · COMPLETED
Trial details
- NCT number
- NCT05574543
- Sponsor
- Angitia Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-07-13
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.